11 studies found for:
11439948 [PUBMED-IDS]
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Active, not recruiting |
Study to Assess the Efficacy of 12 Versus 24 Weeks of Extended Treatment in HCV-Genotype 2/3 Patients
|
||||
| 2 | Unknown † |
12 Week Study of Anti-Viral Effect of Oral UT-231B in Non-cirrhotic Hepatitis C Patients who have Failed Interferon-based Therapy.
|
||||
| 3 | Completed |
Prediction of Hepatic Fibrosis in Patients With Chronic Hepatitis C by Biochemical and Duplex Doppler Indices
|
||||
| 4 | Unknown † |
4-Methylumbelliferone as a Treatment for Chronic HBV/HCV
|
||||
| 5 | Recruiting |
Comparison of Two Triple Regimens for Treatment and Retreatment of Chronic Hepatitis C Infection
|
||||
| 6 | Unknown † |
Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Hepatocellular Carcinoma
|
||||
| 7 |
Completed
Has Results |
Low-Dose Peginterferon and Ribavirin to Treat Chronic Hepatitis C in Patients Infected With HCV Genotype 2 or 3
|
||||
| 8 | Completed |
Prediction of Significant Hepatic Fibrosis in HCV Carriers With PNALT by SAPI- A Validation Study
|
||||
| 9 | Completed |
Gamma Interferon Therapy for Chronic Hepatitis C
|
||||
| 10 | Completed |
S-Adenosyl Methionine (SAMe) to Treat Patients With Chronic Hepatitis C
|
||||
| 11 | Unknown † |
Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Malignancy Other Than Hepatocellular Carcinoma
|
† Indicates status has not been verified in more than two years